These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24549646)

  • 1. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
    Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
    J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
    Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
    Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1 expression in locally invasive and metastatic prostate cancer.
    Chen D; Adenekan B; Chen L; Vaughan ED; Gerald W; Feng Z; Knudsen BS
    Urology; 2004 Feb; 63(2):402-7. PubMed ID: 14972511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model.
    Kumano M; Miyake H; Terakawa T; Furukawa J; Fujisawa M
    BJU Int; 2010 Jul; 106(1):121-7. PubMed ID: 19912186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
    Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression.
    Brimo F; Vollmer RT; Friszt M; Corcos J; Bismar TA
    BJU Int; 2010 Aug; 106(3):418-23. PubMed ID: 20002675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
    Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
    Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
    Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers.
    Grotenhuis BA; Dinjens WN; Wijnhoven BP; Sonneveld P; Sacchetti A; Franken PF; van Dekken H; Tilanus HW; van Lanschot JJ; Fodde R
    J Pathol; 2010 Aug; 221(4):379-89. PubMed ID: 20549647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
    Shariat SF; Svatek RS; Kabbani W; Walz J; Lotan Y; Karakiewicz PI; Roehrborn CG
    BJU Int; 2008 Jan; 101(2):232-7. PubMed ID: 17868422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
    Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
    Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells.
    Itoh T; Terazawa R; Kojima K; Nakane K; Deguchi T; Ando M; Tsukamasa Y; Ito M; Nozawa Y
    Free Radic Res; 2011 Sep; 45(9):1033-9. PubMed ID: 21682664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer.
    Civenni G; Malek A; Albino D; Garcia-Escudero R; Napoli S; Di Marco S; Pinton S; Sarti M; Carbone GM; Catapano CV
    Cancer Res; 2013 Nov; 73(22):6816-27. PubMed ID: 24063893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel.
    Wen X; Li X; Liao B; Liu Y; Wu J; Yuan X; Ouyang B; Sun Q; Gao X
    Urology; 2009 Jun; 73(6):1407-11. PubMed ID: 19362342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Early Disruption of Mitochondrial Function Contributes to Arsenic-Induced Prostate Tumorigenesis.
    Singh B; Kulawiec M; Owens KM; Singh A; Singh KK
    Biochemistry (Mosc); 2016 Oct; 81(10):1089-1100. PubMed ID: 27908234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.